Nano-X Imaging Q2 2025 Earnings Preview: Revenue Expected to Rise 18.5% YoY

Nano-X Imaging (NASDAQ:NNOX) is set to announce Q2 2025 earnings on August 12th. The consensus EPS estimate is -$0.15, and the consensus revenue estimate is $3.2M, a 18.5% Y/Y increase. Over the last two years, NNOX has reported a net loss and declining revenues, with a significant loss in 2023.

Nano-X Imaging (NASDAQ:NNOX), a developer of commercial-grade tomographic imaging devices, is scheduled to release its Q2 2025 earnings on Tuesday, August 12th, before the market opens. The consensus estimates for earnings per share (EPS) and revenue are -$0.15 and $3.2 million, respectively, representing an 18.5% year-over-year (YoY) increase in revenue [2].

Historically, Nano-X Imaging has faced financial challenges. Over the last two years, the company has reported net losses and declining revenues, with a significant loss in 2023. In Q1 2025, the company missed both EPS and revenue estimates [2]. The upcoming earnings report will provide insights into the company's financial health and its ability to turn around its financial performance.

Analysts have been cutting their estimates for Nano-X Imaging in recent months, reflecting concerns about the company's ability to generate sustainable profits. The earnings call on Tuesday will be closely watched by investors and financial professionals to gauge the company's progress and any potential changes in its business strategy.

Nano-X Imaging's earnings report will also include details about its recent collaborations and technological advancements. The company has announced a clinical and educational collaboration with Keiser University, featuring the Nanox.ARC, and has received the MDR CE Mark for HealthOST, an advanced AI-powered software for spine assessment [1]. These developments could have a positive impact on the company's financial performance and its ability to generate revenue.

In conclusion, Nano-X Imaging's Q2 2025 earnings report will be a critical event for investors and financial professionals. The company's ability to meet or exceed consensus estimates and provide a clear path forward will be crucial in determining its future prospects.

References:
[1] https://www.marketbeat.com/earnings/reports/2025-8-12-nano-x-imaging-ltd-stock/
[2] https://seekingalpha.com/news/4483254-nano-x-imaging-q2-2025-earnings-preview